Intaxel 260mg Injection

About Intaxel 260mg Injection

Intaxel 260mg Injection is an anticancer medication used in the treatment of several types of cancer, including breast cancer, non-small cell lung cancer, ovarian cancer, and AIDS-related Kaposis sarcoma. It works by disrupting the growth and division of cancer cells, helping to slow or stop the progression of the disease. Depending on the patient's condition and treatment plan, Intaxel 260mg Injection may be administered alone or in combination with other chemotherapy medicines. This medication is not recommended for individuals with severe liver impairment, uncontrolled infections, or significantly low white blood cell or platelet counts. It is also generally not advised for children and adolescents under 18 years of age. Before starting treatment, patients should inform their healthcare provider about any history of heart disease or other medical conditions, as additional monitoring may be required. Serious allergic reactions may occur during administration, making treatment under medical supervision essential. Patients should use effective contraception during therapy and for at least six months after the final dose to avoid pregnancy-related risks. Additionally, because the formulation may contain alcohol, individuals with alcoholism or alcohol-related health concerns should discuss the potential risks with their doctor before receiving Intaxel 260mg Injection. Regular monitoring throughout treatment helps ensure safety and optimize treatment outcomes.